Chemo-enzymatic cascade processes are invaluable due to their ability to rapidly construct high-value products from available feedstock chemicals in a one-pot relay manner. In a patent, 22013-33-8, name is 2,3-Dihydrobenzo[b][1,4]dioxin-6-amine, introducing its new discovery. name: 2,3-Dihydrobenzo[b][1,4]dioxin-6-amine
Three fused polycyclic aryl fragments, namely, naphthyl, methoxynaphthyl, and pyrenyl have been used to construct blue-emissive phenanthroimidazole-functionalized target molecules, i.e., 1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-(naphthalen-1-yl)-1H-phenanthro[9,10-d]imidazole (1), 1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-(1-methoxynaphthalen-4-yl)-1H-phenanthro[9,10-d]imidazole (2), and 1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-(pyren-10-yl)-1H-phenanthro[9,10-d]imidazole (3). The up-conversion of triplets to singlets via a triplet-triplet annihilation (TTA) process is dominant in these compounds due to 2ET1 > ES1. The pyrenyl dihydrobenzodioxin phenanthroimidazole (3)-based nondoped OLED exhibits blue emission (450 nm) with CIE (0.15, 0.14), a luminance of 53-890 cd m-2, power efficiency of 5.86 lm W-1, external quantum efficiency of 5.30%, and current efficiency of 6.90 cd A-1. The efficient device performance of pyrenyl dihydrobenzodioxin phenanthroimidazole is due to the TTA contribution to the electroluminescent process.
If you’re interested in learning more about , below is a message from the blog Manager. name: 2,3-Dihydrobenzo[b][1,4]dioxin-6-amine